Literature DB >> 15017029

Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors.

T Akiyoshi1, K Uchida, S Tateyama.   

Abstract

To study the ectopic chondrogenesis in canine mammary mixed tumors, the expression of bone morphogenetic protein-6 (BMP-6) and specific BMP receptors (BMPRs), BMPR-IA, BMPR-IB, and BMPR-II, was examined using immunohistochemical and immunoblot analysis in 39 canine mammary gland tumors. Immunohistochemically, BMP-6 and all three types of BMPRs were coexpressed in the myoepithelial cells and chondrocytes in six of eight benign mixed tumors. In complex adenomas, myoepithelial cells showed an expression pattern of BMP-6, BMPR-IA, and BMPR-II similar to those in benign mixed tumors, whereas immunoreactivity for BMPR-IB was very mild. The myoepithelial cells proliferating within the basement membrane showed more intense immunoreactivity for BMP-6 and all BMPRs as compared with those proliferating in the interstitial areas. Western blotting analysis revealed immunopositive bands at 40-45 kDa for BMP-6 in the samples from simple and complex adenomas and benign mixed tumors. The BMPR-IB-specific bands at 45 kDa were most detected in benign mixed tumors. Because among BMPRs, BMPR-IB is thought to be the major receptor for BMP-6 for primary chondrogenesis, these findings suggest that the expression of BMP and its receptors on the myoepithelial cells might play a role in the ectopic cartilage formation in canine mammary gland tumors, especially in benign mixed tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017029     DOI: 10.1354/vp.41-2-154

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  8 in total

1.  BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression.

Authors:  Wei Ren; Xiaoxiao Sun; Ke Wang; Honglei Feng; Yuehong Liu; Chang Fei; Shaoheng Wan; Wei Wang; Jinyong Luo; Qiong Shi; Min Tang; Guowei Zuo; Yaguang Weng; Tongchuan He; Yan Zhang
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

2.  PTHrP inhibits BMP-6 expression through the PKA signaling pathway in breast cancer cells.

Authors:  Dong Mi; Ming Zhang; Ji-dong Yan; Jie Zhang; Xu Wang; Qing Wang; Shuang Yang; Tian-hui Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-18       Impact factor: 4.553

3.  Expression and synthesis of bone morphogenetic proteins by osteoclasts: a possible path to anabolic bone remodeling.

Authors:  Rama Garimella; Sarah E Tague; Jianghong Zhang; Frank Belibi; Niru Nahar; Ben Hua Sun; Karl Insogna; Jinxi Wang; H Clarke Anderson
Journal:  J Histochem Cytochem       Date:  2008-03-03       Impact factor: 2.479

4.  Methylation signature of lymph node metastases in breast cancer patients.

Authors:  Zeinab Barekati; Ramin Radpour; Qing Lu; Johannes Bitzer; Hong Zheng; Paolo Toniolo; Per Lenner; Xiao Yan Zhong
Journal:  BMC Cancer       Date:  2012-06-13       Impact factor: 4.430

5.  Unilateral mixed adenoma of the third eyelid lacrimal gland in a boxer dog.

Authors:  Jeremy M McKeever; Kim M Newkirk
Journal:  Clin Case Rep       Date:  2022-08-18

6.  Diverse bone morphogenetic protein expression profiles and smad pathway activation in different phenotypes of experimental canine mammary tumors.

Authors:  Helena Wensman; Nils-Erik Heldin; Gunnar Pejler; Eva Hellmén
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

7.  Canine mammary mixed tumours: a review.

Authors:  Geovanni Dantas Cassali; Angélica Cavalheiro Bertagnolli; Enio Ferreira; Karine Araújo Damasceno; Conrado de Oliveira Gamba; Cecília Bonolo de Campos
Journal:  Vet Med Int       Date:  2012-10-21

8.  BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells.

Authors:  Shuang Yang; Jun Du; Zhaoqi Wang; Wei Yuan; Yuhuan Qiao; Ming Zhang; Jie Zhang; Songyuan Gao; Jian Yin; Baocun Sun; Tianhui Zhu
Journal:  BMC Cancer       Date:  2007-11-13       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.